GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » Market Cap

Atomo Diagnostics (ASX:AT1) Market Cap : A$10.87 Mil (As of Apr. 01, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Atomo Diagnostics's share price for the quarter that ended in Dec. 2024 was A$0.019. Atomo Diagnostics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 639.20 Mil. Therefore, Atomo Diagnostics's market cap for the quarter that ended in Dec. 2024 was A$12.14 Mil.

Atomo Diagnostics's quarterly market cap increased from Dec. 2023 (A$14.06 Mil) to Jun. 2024 (A$15.98 Mil) but then declined from Jun. 2024 (A$15.98 Mil) to Dec. 2024 (A$12.14 Mil).

Atomo Diagnostics's annual market cap declined from Jun. 2022 (A$31.97 Mil) to Jun. 2023 (A$12.56 Mil) but then increased from Jun. 2023 (A$12.56 Mil) to Jun. 2024 (A$15.98 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Atomo Diagnostics's Enterprise Value for Today is A$8.17 Mil.


Atomo Diagnostics Market Cap Historical Data

The historical data trend for Atomo Diagnostics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atomo Diagnostics Market Cap Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Market Cap
190.77 105.19 31.97 12.56 15.98

Atomo Diagnostics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 30.83 12.56 14.06 15.98 12.14

Competitive Comparison of Atomo Diagnostics's Market Cap

For the Medical Devices subindustry, Atomo Diagnostics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atomo Diagnostics's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's Market Cap distribution charts can be found below:

* The bar in red indicates where Atomo Diagnostics's Market Cap falls into.


;
;

Atomo Diagnostics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Atomo Diagnostics's Market Cap for the fiscal year that ended in Jun. 2024 is calculated as

Market Cap (A: Jun. 2024 )=Share Price (A: Jun. 2024 )*Shares Outstanding (EOP) (A: Jun. 2024 )
=A$0.025*639.202
=A$15.98

Atomo Diagnostics's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=A$0.019*639.202
=A$12.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atomo Diagnostics  (ASX:AT1) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Atomo Diagnostics Market Cap Related Terms

Thank you for viewing the detailed overview of Atomo Diagnostics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Atomo Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines